Avalon Group

Avalon Biomedical is a Hong Kong-based healthcare group that develops and commercializes biomedical technologies across four main areas: public health and infection control, diagnostics, medical devices, and pharmaceuticals. The company appears to operate through multiple affiliated businesses, including Emerging Viral Diagnostics for multiplex infectious disease testing, Avalon SteriTech for hygiene and disinfection solutions, and Nansha Biologics for biologic therapeutics. Its best-known technology is the Avalon Automated Multiplex System (AAMST), an automated diagnostic platform designed to detect more than 40 pathogens in a single test. Avalon positions itself as a commercialization and operating platform that supports innovation from research and funding through manufacturing and market entry. Overall, the group is more diversified than a typical single-asset biotech and is best characterized as a health technology platform company with diagnostics, medtech, infection-control, and early-stage biopharma activities.